Latest Insider Transactions at Lb Pharmaceuticals Inc (LBRX)
This section provides a real-time view of insider transactions for Lb Pharmaceuticals Inc (LBRX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of LB PHARMACEUTICALS INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of LB PHARMACEUTICALS INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 12
2025
|
Deep Track Biotechnology Master Fund, Ltd. |
BUY
Open market or private purchase
|
Indirect |
666,666
+50.0%
|
$9,999,990
$15.0 P/Share
|
|
Sep 12
2025
|
Deep Track Biotechnology Master Fund, Ltd. |
BUY
Open market or private purchase
|
Direct |
2,000,000
+42.68%
|
$30,000,000
$15.0 P/Share
|
|
Sep 12
2025
|
Deep Track Biotechnology Master Fund, Ltd. |
BUY
Conversion of derivative security
|
Direct |
686,138
+50.0%
|
-
|
|
Sep 12
2025
|
Ran Nussbaum |
BUY
Open market or private purchase
|
Indirect |
1,000,000
+41.46%
|
$15,000,000
$15.0 P/Share
|
|
Sep 12
2025
|
Ran Nussbaum |
BUY
Conversion of derivative security
|
Indirect |
411,681
+50.0%
|
-
|
|
Sep 12
2025
|
Pontifax Management 4 G.P. (2015) Ltd. |
BUY
Open market or private purchase
|
Indirect |
1,000,000
+41.46%
|
$15,000,000
$15.0 P/Share
|
|
Sep 12
2025
|
Pontifax Management 4 G.P. (2015) Ltd. |
BUY
Conversion of derivative security
|
Indirect |
411,681
+50.0%
|
-
|
|
Sep 12
2025
|
Vida Ventures Gp Iii, L.L.C. |
BUY
Open market or private purchase
|
Indirect |
333,333
+27.43%
|
$4,999,995
$15.0 P/Share
|
|
Sep 12
2025
|
Vida Ventures Gp Iii, L.L.C. |
BUY
Conversion of derivative security
|
Indirect |
548,910
+50.0%
|
-
|